Mechanisms of arrhythmias in heart failure

Journal of Cardiovascular Electrophysiology

Volumn 9, Issue 2, 1998, Pages 208-221

  Vermeulen, Jessica T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Automaticity; Delayed afterdepolarizations; Early afterdepolarizations; Heart failure; Triggered activity

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE;

ADRENERGIC STIMULATION; CLINICAL TRIAL; ELECTROLYTE DISTURBANCE; HEART AUTOMATICITY; HEART DEPOLARIZATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; MORTALITY; MUSCLE STRETCHING; NONHUMAN; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; REVIEW;

EID: 0031952866     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1998.tb00902.x     Document Type: Review

References (129)

1. Packer M: Prolonging life in patients with congestive heart failure: The next frontier. Circulation 1987;75: IV-1-IV-8.
2. Bonneux L, Barendregt JJ, Meeter K, et al: Estimating clinical morbidity due to ischemic heart disease and congestive heart failure - The future rise of heart failure. Am J Public Health 1994;84:20-28.
3. Dargie HJ, Cleland JGF, Leckie BJ, et al: Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation 1987;75:IV-98-IV-107.
4. Hofmann T, Meinertz T, Kasper W, et al: Mode of cardiac death in idiopathic dilated cardiomyopathy: A multivariate analysis of prognostic determinants. Am Heart J 1988;116:1455-1463.
5. Wilson JR, Schwartz JS, St. John Sutton M, et al: Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983;2:403-410.
6. Rademaker JME: Arrhythmogenesis During the Development of Heart Failure in Rabbits. Ph.D. Thesis, University of Amsterdam, Amsterdam, The Netherlands, 1997.
7. De Maria R. Gavazzi A, Caroli A, et al: Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Am J Cardiol 1992;69: 1451-1457.
8. Bjarnason I, Ardason T, Johnsson S: Cardiac arrhythmias in hypertrophic cardiomyopathy. Br Heart J 1982;48:198-203.
9. Pogwizd SM, Hoyt RH, Saffitz JE, et al: Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 1992;86:1872-1887.
10. Sabbah HN, Goldberg AD, Schoels W, et al: Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: Relation to haemodynamics and sympathoadrenergic activation. Eur Heart J 1992;13:1562-1572.
11. Pogwizd SM: Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits. Circulation 1995; 92:1034-1048.
12. Rademaker H, Wilms-Schopman FJG, Vermeulen JT, et al: Analysis of arrhythmias and sinus rhythm in rabbits with heart failure. (Abstract) Heart Failure 1997;4:711.
13. Kjekshus J: Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990;65:42-48.
14. Chakko CS, Gheorghiade M: Ventricular arrhythmias in severe heart failure: Incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J 1985;109:497-504.
15. Holmes J, Kubo SH, Cody RJ, et al: Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985;55:146-151.
16. Gradman A, Deedwania P, Cody R, et al: Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989;14:564-570.
17. Packer M: Sudden and unexpected death in patients with congestive heart failure: A second frontier. Circulation 1985;72:681-685.
18. Califf RM, McKinnis RA, Burke J, et al: Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing catheterization for coronary artery disease. Am J Cardiol 1982;50:23-31.
19. Olshausen KV, Schafer A, Mehmel HC, et al: Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 1984;51:195-201.
20. Middlekauff HR, Stevenson WG, Stevenson LW: Prognostic significance of atrial fibrillation in advanced heart failure. Circulation 1991;84:40-48.
21. Stevenson LW, Tillisch JH, Hamilton M, et al: Importance of hemodynamic response to therapy in predicting survival with ejection fraction <20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990;66:1348-1354.
22. Romeo F, Pelliccia F, Cianfrocca C, et al: Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol 1989;63:138-140.
23. Doval HC, Nul DR, Grancelli HO, et al: Nonsustained ventricular tachycardia in severe heart failure: Independent marker of increased mortality due to sudden death. Circulation 1996;94:3198-3203.
24. Packer M: Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 1992;85:I-50-I-56.
25. Luu M, Stevenson WG, Warner Stevenson L, et al: Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989;80:1675-1680.
26. Stevenson WG, Stevenson LW, Middlekauff HR, et al: Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993;88:2953-2961.
27. Goldman S, Johnson G, Cohn JN, et al: Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(Suppl):VI-24-VI-31.
28. Feng QP, Hedner T, Andersson B, et al: Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J 1994;71:261-267.
29. Koilpillai C, Quinones MA, Greenberg B, et al: Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction. Am J Cardiol 1996; 77:606-611.
30. Singh SN: Congestive heart failure and arrhythmias: Therapeutic modalities. J Cardiovasc Electrophysiol 1997;8:89-97.
31. Pratt CM, Eaton T, Francis M, et al: The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: A dangerous imbalance in the risk-benefit ratio. Am Heart J 1989;118:433-440.
32. Hallstrom A, Pratt CM, Greene HL, et al: Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: Analysis of the Cardiac Arrhythmia Suppression Trial. J Am Coll Cardiol 1995;25:1250-1257.
33. Meissner MD, Kay HR, Horowitz LN, et al: Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Am J Cardiol 1988;61:1050-1055.
34. Fozzard HA: Afterdepolarizations and triggered activity. Basic Res Cardiol 1992;87:105-113
35. Aronson RS: Afterpotentials and triggered activity in hypertrophied myocardium from rats with renal hypertension. Circ Res 1981;48:720-727.
36. Ben-David J, Zipes DP, Ayers GM, et al: Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administraton of BAY K 8644. J Am Coll Cardiol 1992;20:1576-1584.
37. Wiederhold KF, Nilius B: Increased sensitivity of ventricular myocardium to intracellular calcium-overload in Syrian cardiomyopathic hamster. Biomed Biochim Acta 1986;45:1333-1337.
38. Vermeulen JT, McGuire MA, Opthof T, et al: Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res 1994;28:1547-1554.
39. Gelband H, Bassett AL: Depressed transmembrane potentials during experimentally induced ventricular failure in cats. Circ Res 1973;32:625-634.
40. Keung ECH, Aronson RS: Non-uniform electrophysiological properties and electrotonic interaction in hypertrophied rat myocardium. Circ Res 1981;49: 150-158.
41. Nordin C, Siri F, Aronson RS: Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea-pig hearts. J Mol Cell Cardiol 1989;21:729-739.
42. 2+ handling in hypertrophied myocardium from rats with renal hypertension. Heart Failure 1989;5:143-154.
43. Gwathmey JK, Copelas L, MacKinnon R, et al: Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987;61:70-76.
44. Bril A, Forest M, Gout B: Ischemia and reperfusion-induced arrhythmias in rabbits with chronic heart failure. Am J Physiol 1991;261:H301-H307.
45. Beuckelmann DJ, Nabauer M, Erdmann E: Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992;85:1046-1055.
46. Shenasa H, Calderone A, Vermeulen M, et al: Chronic doxorubicin induced cardiomyopathy in rabbits: Mechanical, intracellular action potential, and β-adrenergic characteristics of the failing myocardium. Cardiovasc Res 1990;24:591-604.
47. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:379-385.
48. Kleiman RB, Houser SR: Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol 1989;256:H1450-H1461.
49. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 1993;73:777-782.
50. Gadsby DC: Influence of the sodium pump current on electrical activity of cardiac cells. In Blaustein MP, Lieberman M, eds: Electrogenic Transport: Fundamental Principles and Physiological Implications. Raven Press, New York, 1984, pp. 215-235.
51. Gadsby DC, Cranefield PF: Electrogenic sodium extrusion in cardiac Purkinje fibers. J Gen Physiol 1979; 73:819-837.
52. Kim CH, Fan THM, Kelly PF, et al: Isoform-specific regulation of myocardial Na,K-ATPase α-subunit in congestive heart failure. Circulation 1994;89:313-320.
53. 3H]ouabain binding sites in sarcolemma prepared from hearts of spontaneously hypertensive rats. Hypertension 1983;5:682-688.
54. Houser SR, Freeman AR, Jaeger JM, et al: Resting potential changes associated with Na-K pump in failing heart muscle. Am J Physiol 1981;240:H168-H176.
55. Norgaard A, Baandrup U, Larsen JS, et al: Heart Na,K-ATPase activity in cardiomyopathic hamsters as estimated from K-dependent 3-O-MFPase activity in crude homogenates. J Mol Cell Cardiol 1987;19: 589-594.
56. +-ATPase in tachycardia induced cardiomyopathy. J Mol Cell Cardiol 1992;24:277-294.
57. Shamraj OI, Grupp IL, Grupp G, et al: Characterisation of the Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovasc Res 1993;27:2229-2237.
58. Smith TW, Antma EM, Friedman PL, et al: Digitalis glycosides: Mechanisms and manifestations of toxicity (Part II). Prog Cardiovasc Dis 1984;26:495-540.
59. +-ATPase. Biochim Biophys Acta 1989;988:185-220.
60. Pye MP, Cobbe SM: Arrhythmogenesis in experimental models of heart failure: The role of increased load. Cardiovasc Res 1996;32:248-257.
61. Gwathmey JK, Slawsky MT, Hajjar RJ, et al: Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 1990;85:1599-1613.
62. Gwathmey JK, Morgan JP: Altered calcium handling experimental pressure overload hypertrophy in the ferret. Circ Res 1985;57:836-843.
63. Bailey B, Houser SR: Sarcoplasmic reticulum-related changes in cytosolic calcium in pressure-overload-induced feline LV hypertrophy. Am J Physiol 1993; 265:H2009-H2016.
64. 2+ release leads to heterogeneity of contractile and electrical properties of the heart. Basic Res Cardiol 1992;87:93-104.
65. 2+ release in the heart. Cardiovasc Res 1992;26:193-214.
66. 2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 1990;66:554-564.
67. Limas CJ, Olivari MT, Goldenberg IF, et al: Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy. Cardiovasc Res 1987;21: 601-605.
68. Lindenmayer GE, Sordahl LA, Harigaya S, et al: Some biochemical studies on subcellular systems isolated from fresh recipient human cardiac tissue obtained during transplantation. Am J Cardiol 1971; 27:277-283.
69. El Houda Bouanani N, Perennec J, Ezzaher A, et al: Sarcoplasmic reticulum function abnormalities in rabbit failing hearts. C R Acad Sci Paris, Life Sci 1994; 317:825-831.
70. 2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res 1989;65: 1141-1144.
71. Cory CR, McCutcheon LJ, O'Grady M, et al: Compensatory downregulation of myocardial Ca channel in SR from dogs with heart failure. Am J Physiol 1993;264:H926-H937.
72. 2+ exchanger in end stage human heart failure. Circ Res 1994;75:443-453.
73. 2+ content in young spontaneously hypertensive rats. J Cardiovasc Pharmacol 1986;8:S130-S135.
74. Hanf R, Drubaix I, Marotte F, et al: Rat cardiac hypertrophy: Altered sodium-calcium exchange activity in sarcolemmal vesicles. FEBS Lett 1988;236:145-149.
75. Andrawis NS, Kuo TH, Giacomelli F, et al: Altered calcium regulation in the cardiac plasma membrane in experimental renal hypertension. J Mol Cell Cardiol 1988;20:625-634.
76. Cameron JS, Myerburg RJ, Wong SS, et al: Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload. J Am Coll Cardiol 1983;2:481-487.
77. Rossner KL, Sachs HG: Electrophysiological study of Syrian hamster cardiomyopathy. Cardiovasc Res 1978;12:436-443.
78. Gilmour RF, Heger JJ, Prystowsky EN, et al: Cellular electrophysiologic abnormalities of diseased human ventricular myocardium. Am J Cardiol 1983;51:137-144.
79. De Bakker JMT, Van Capelle FJL, Janse MJ, et al: Macroreentry in the infarcted human heart: The mechanism of ventricular tachycardias with a "focal" activation pattern. J Am Coll Cardiol 1991;18:1005-1014.
80. De Bakker JMT, Van Capelle FJL, Janse MJ, et al: Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: Electrophysiology and anatomic correlation. Circulation 1988;77:589-606.
81. Ho KKL, Anderson KM, Kannel WB, et al: Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993;88:107-115.
82. Pogwizd SM: Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation 1994;90:1441-1458.
83. Martins JB, Kim W, Marcus ML: Chronic hypertension and left ventricular hypertrophy facilitate induction of sustained ventricular tachycardia in dogs 3 hours after left circumflex coronary artery occlusion. J Am Coll Cardiol 1989;14:1365-1373.
84. Winterton SJ, Turner MA, O'Gorman DJ, et al: Hypertrophy causes delayed conduction in human and guinea pig myocardium: Accentuation during ischemia. Cardiovasc Res 1994;28:47-54.
85. Unverferth DV, Baker PB, Pearce LI, et al: Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. Am J Cardiol 1987;59:932-936.
86. Krayenbuehl HP, Hess OM, Monrad HS, et al: Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989;79:744-755.
87. Franz MR, Bargheer K, Swerdlow CD, et al: Increased dispersion of action potential and local repolarization time in human left ventricular hypertrophy. (Abstract) Circulation 1986;74:II-483.
88. Kowey PR, Friehling TD, Sewter J, et al: Effects of left ventricular hypertrophy: Effect of calcium and potassium channel blockade. Circulation 1991;83: 2067-2075.
89. Vermeulen JT, Tan HL, Rademaker H, et al: Electrophysiologic and extracellular ionic changes during acute ischemia in failing and normal rabbit ventricle. J Mol Cell Cardiol 1996;28:123-131.
90. + channels are altered in hypertrophied ventricular myocytes. Am J Physiol 1988;255: H1254-H1258.
91. Smith WT, Fleet WF, Johnson TA, et al: The 1-B phase of ventricular arrhythmias in ischemic in situ porcine heart is related to changes in cell-to-cell electrical coupling. Circulation 1994;4:I-524.
92. Dekker LRC, Rademaker H, Vermeulen JT, et al: Cellular uncoupling during ischemia in hypertrophied and failing rabbit ventricular myocardium. Effects of preconditioning. Circulation 1998; (In press).
93. Chidsey CA, Braunwald E, Morrow AG, et al: Myocardial norepinephrine concentration in man. N Engl J Med 1963;269:653-658.
94. Bristow MR, Ginsburg R, Minobe W, et al: Decreased catecholamine sensitivity and B-adrenergic-receptor density in failing human hearts. N Engl J Med 1982;307:205-211.
95. Daly PA, Sole MJ: Myocardial catecholamines and the pathophysiology of heart failure. Circulation 1990;82:I-35-I-43.
96. Gilson N, El Houda Bouanani N, Corsin A, et al: Left ventricular function and β-adrenoceptors in rabbit failing heart. Am J Physiol 1990;258:H634-H641.
97. Pierpont GL, Francis GS, DeMaster EG, et al: Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure. Am J Cardiol 1987;60:316-321.
98. Beau SL, Tolley TK, Saffitz JE: Heterogeneous transmural distribution of β-adrenergic receptor subtypes in failing human hearts. Circulation 1993;88:2501-2509.
99. Dyckner T, Wester PO: Potassium/magnesium depletion in patients with cardiovascular disease. Am J Med 1987;82:11-17.
100. Valdemarsson S, Bergdahl A, Edvinsson L: Relationships between plasma levels of catecholamines and neuropeptides and the survival time in patients with congestive heart failure. J Intern Med 1994;235:595-601.
101. Cohn JN, Levine TB, Olivari MT, et al: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-823.
102. Rector TS, Cohn JN: Prognosis in congestive heart failure. Annu Rev Med 1994;45:341-350.
103. Coronel R, Fiolet JWT, Wilms-Schopman FJG, et al: Distribution of extracellular potassium and its relation to electrophysiologic changes during acute ischemia in the isolated perfused porcine heart. Circulation 1988;77:1125-1138.
104. Calkins H, Allman K, Bolling S, et al: Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation 1993;88:172-179.
105. Reiter MJ: Effects of mechano-electrical feedback: Potential arrhythmogenic influence in patients with congestive heart failure. Cardiovasc Res 1996;32:44-51.
106. Franz MR, Cima R, Wang D, et al: Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias [published erratum appears in Circulation 1992;86:1663]. Circulation 1992;86:968-978.
107. Franz MR, Burkhoff D, Yue DT, et al: Mechanically induced action potential changes and arrhythmia in isolated and in situ canine hearts. Cardiovasc Res 1989;23:213-223.
108. Zabel M, Koller BS, Sachs F, et al: Stretch-induced voltage changes in the isolated beating heart: Importance of the timing of stretch and implications for stretch-activated ion channels. Cardiovasc Res 1996; 32:120-130.
109. Hansen DE, Craig CS, Hondeghem LM: Stretch-induced arrhythmias in the isolated canine ventricle: Evidence for the importance of mechanoelectrical feedback. Circulation 1990;81:1094-1105.
110. Kaufmann R, Theophile U: Autonomously promoted extension effect in Purkinje fibers, papillary muscles and trabeculae carneae of rhesus monkeys [in German]. Pflügers Arch 1967;297:174-189.
111. Wang Z, Taylor K, Denney WD, et al: Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle. Circulation 1994;90:2022-2031.
112. Rosen MR, Reder RF: Does triggered activity have a role in the genesis of cardiac arrhythmias? Ann Intern Med 1981;94:794-801.
113. Leclercq JF, Maisonblanche P, Cauchemez B, et al: Respective role of sympathetic tone and of cardiac pauses in the genesis of 62 cases of ventricular fibrillation recorded during Holter monitoring. Eur Heart J 1988;9:1276-1283.
114. Coumel P, Leenhardt A, Jouven X, et al: New insights into the mechanisms of sudden cardiac death gained by noninvasive means. In Allessie MA, Fromer M, eds: Atrial and Ventricular Fibrillation: Mechanisms and Device Therapy. Futura Publishing Co., Inc., Armonk, NY, 1997, pp. 37-51.
115. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: The Sicilian Gambit. Circulation 1991;84:1831-1851.
116. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al: Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial. J Am Coll Cardiol 1992;19:842-850.
117. Cohn JN, Johnson G, Ziesche S: A comparison of enalapril with isosorbide-dinitrate in the treatment of congestive heart failure. N Engl J Med 1991;325: 303-310.
118. Fletcher RD, Cintron GB, Johnson G, et al: Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. Circulation 1993;87(Suppl):VI-49-VI-55.
119. Francis GS, Cohn JN, Johnson G, et al: Plasma norepinephrine, plasma renin activity, and congestive heart failure: Relations to survival and the effects of therapy in V-HeFT II. Circulation 1993;87:VI-40-VI-48.
120. Konstam MA, Rousseau MF, Kronenberg MW, et al: Effects of angiotensin converting enzyme inhibitor enalapril on the long-term progression of ventricular dysfunction in patients with heart failure. Circulation 1992;80:431-438.
121. Bristow MR, Oconnell JB, Gilbert EM, Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation 1994;89:1632-1642.
122. Packer M, Bristow MR, Cohn JN, et al: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group [see comments]. N Engl J Med 1996; 334:1349-1355.
123. Kjekshus JK: Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:43F-49F.
124. Feldman MD, Gwathmey JK, Phillips P, et al: Reversal of force-frequency relationship in working myocardium from patients with end-stage heart failure. J Am Coll Cardiol 1988;19:842-850.
125. Nicklas JM, Mckenna WJ, Steward RA, et al: Prospective, double blind, placebo control trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ectopy. Am Heart J 1991;122:1010-1121.
126. Singh SN, Fletcher RD, Fisher SG, et al: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure [see comments]. N Engl J Med 1995;333:77-82.
127. Doval HC, Nul DR, Vanvelli HO, et al: Randomized trial of low dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-498.
128. Julian DG, Camm AJ, Frangin G, et al., for the European Myocardial Infarct Amiodarone Trial Investigators: Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-674.
129. Nul DR, Doval HC, Grancelli HO, et al: Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicentricos en Argentina. J Am Coll Cardiol 1997;29:1199-1205.